Clinical trials
Recruiting Esophageal Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| Bayer | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Myeloid Therapeutics | 1 |
| Second Life Therapeutics | 1 |
| UMC Utrecht | 1 |
| ViroMissile, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 11 |
| Stomach Neoplasms | 7 |
| Urinary Bladder Neoplasms | 7 |
| Ovarian Neoplasms | 6 |
| Pancreatic Neoplasms | 6 |
| Uterine Cervical Neoplasms | 6 |
| Breast Neoplasms | 5 |
| Colorectal Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 4 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.